Translation control can shape TP53-dependent cell fate.
Mol Cell Oncol
; 7(5): 1767483, 2020.
Article
em En
| MEDLINE
| ID: mdl-32944629
ABSTRACT
The search for mechanisms underlying different cellular responses to the treatment with Nutlin-3, an MDM2 inhibitor that unleashes p53, revealed a translational control mechanism involving the RNA binding proteins PCBP2 and, particularly, DHX30. Sifting through a multi-functional p53-dependent transcriptional output, this translational control can modulate the activation of cell death pathways.
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article